Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirayama, M.
Right arrow Articles by Silberberg, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirayama, M.
Right arrow Articles by Silberberg, D. H.
NEUROLOGY 1986;36:276
© 1986 American Academy of Neurology

Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls

Mikio Hirayama, Robert P. Lisak and Donald H. Silberberg

Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA.

We examined serum-mediated cytotoxicity on cultured rat oligodendrocytes, using serum from patients with acute or chronic progressive multiple sclerosis and normal controls. We found heat-labile serum factors in serum from MS and also in controls. The cytotoxic effects of MS and normal sera were not restored by adding a source of complement. Despite apparent lack of disease specificity, such factors might damage oligodendrocytes if they gained access to these cells through a damaged blood-brain barrier in MS or other disorders.

Address correspondence and reprint requests to Dr. Lisak, Department of Neurology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104.

Supported by grants from NIH (NS 11037) and the National Multiple Sclerosis Society of the United States of America.

Accepted for publication June 18, 1985.




This article has been cited by other articles:


Home page
 Mult SclerHome page
R. P Lisak
In vitro studies of glial cells: what can we learn about demyelinating diseases?
Multiple Sclerosis, November 1, 1996; 2(4): 173 - 178.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
S. T. O'Keeffe
Restless Legs Syndrome: A Review
Arch Intern Med, February 12, 1996; 156(3): 243 - 248.
[Abstract] [PDF]

Home page
 Mult SclerHome page
J Zajicek and A Compston
Mechanisms of damage and repair in multiple sclerosis -- a review
Multiple Sclerosis, June 1, 1995; 1(2): 61 - 72.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
A. Vighetto, J. C. Froment, M. Trillet, and G. Aimard
Magnetic Resonance Imaging in Familial Paroxysmal Ataxia
Arch Neurol, May 1, 1988; 45(5): 547 - 549.
[Abstract] [PDF]